303 related articles for article (PubMed ID: 27427840)
1. Antipsychotic Medication Prescribing Practices Among Adult Patients Discharged From State Psychiatric Inpatient Hospitals.
Ortiz G; Hollen V; Schacht L
J Psychiatr Pract; 2016 Jul; 22(4):283-97. PubMed ID: 27427840
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland.
Jaracz J; Tetera-Rudnicka E; Kujath D; Raczyńska A; Stoszek S; Czernaś W; Wierzbiński P; Moniakowski A; Jaracz K; Rybakowski J
Pharmacol Rep; 2014 Aug; 66(4):613-7. PubMed ID: 24948062
[TBL] [Abstract][Full Text] [Related]
3. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
[TBL] [Abstract][Full Text] [Related]
4. Best practices: An initiative to curtail the use of antipsychotic polypharmacy in a state psychiatric hospital.
Patrick V; Schleifer SJ; Nurenberg JR; Gill KJ
Psychiatr Serv; 2006 Jan; 57(1):21-3. PubMed ID: 16399958
[TBL] [Abstract][Full Text] [Related]
5. Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.
Santone G; Bellantuono C; Rucci P; Picardi A; Preti A; de Girolamo G
Pharmacoepidemiol Drug Saf; 2011 May; 20(5):441-9. PubMed ID: 21523847
[TBL] [Abstract][Full Text] [Related]
6. Assessment of inpatient psychiatric readmission risk among patients discharged on an antipsychotic polypharmacy regimen: A retrospective cohort study.
Boskailo E; Malkoc A; McCurry DB; Venter J; Drachman D; Ramos GM
Acta Med Acad; 2017 Nov; 46(2):133-144. PubMed ID: 29338277
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification.
Carmona-Huerta J; Castiello-de Obeso S; Ramírez-Palomino J; Duran-Gutiérrez R; Cardona-Muller D; Grover-Paez F; Fernández-Dorantes P; Medina-Dávalos R
BMC Psychiatry; 2019 Feb; 19(1):78. PubMed ID: 30791883
[TBL] [Abstract][Full Text] [Related]
8. Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective study.
Biancosino B; Barbui C; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2005 Nov; 20(6):305-9. PubMed ID: 16192838
[TBL] [Abstract][Full Text] [Related]
9. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic medication coprescribing in a large state hospital system.
Jaffe AB; Levine J
Pharmacoepidemiol Drug Saf; 2003; 12(1):41-8. PubMed ID: 12616846
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.
Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR
Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution.
Procyshyn RM; Kennedy NB; Tse G; Thompson B
Can J Psychiatry; 2001 May; 46(4):334-9. PubMed ID: 11387789
[TBL] [Abstract][Full Text] [Related]
14. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
[TBL] [Abstract][Full Text] [Related]
16. Patterns of antipsychotics' prescription in Portuguese acute psychiatric wards: A cross-sectional study.
Campos Mendes J; Azeredo-Lopes S; Cardoso G
Psychiatry Res; 2016 Dec; 246():142-148. PubMed ID: 27693867
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
[TBL] [Abstract][Full Text] [Related]
18. Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions.
Chengappa KN; Sheth S; Brar JS; Parepally H; Marcus S; Gopalani A; Palmer A; Baker RW; Schooler NR
J Clin Psychiatry; 1999 Jun; 60(6):373-8. PubMed ID: 10401915
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic utilisation and polypharmacy in Italian residential facilities: a survey.
Ghio L; Natta W; Gotelli S; Ferrannini L;
Epidemiol Psychiatr Sci; 2011 Jun; 20(2):171-9. PubMed ID: 21714364
[TBL] [Abstract][Full Text] [Related]
20. The pattern of pharmacological treatment of bipolar patients discharged from psychiatric units in Poland.
Jaracz J; Rudnicka ET; Bierejszyk M; Witczyk K; Raczyńska A; Nowak W; Pisarczyk A; Woźniak K; Czernaś W; Moniakowski A; Jaracz K
Pharmacol Rep; 2018 Aug; 70(4):694-698. PubMed ID: 29933206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
